Fresenius Files Tocilizumab Biosimilar With EMA

Follows Earlier Announcement Of Kabi’s US FDA Filing For Actemra/RoActemra Rival

 
• By David Wallace
EU US Cogs Flags
Fresenius has now submitted tocilizumab in both the US and EU • Source: Shutterstock

More from Biosimilars

More from Products